Renasant Financials

RNST

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Financial Profile 64/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth

Renasant's revenue grew 11.3% year-over-year to $887.8M, a solid pace of expansion. This earns a growth score of 61/100.

Leverage

100

Renasant carries a low D/E ratio of 0.16, meaning only $0.16 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Cash Flow

Renasant converts 13.0% of revenue into free cash flow ($115.8M). This strong cash generation earns a score of 65/100.

Returns

Renasant generates a 7.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 29/100. This is up from 6.3% the prior year.

Piotroski F-Score Neutral

5/9

Renasant passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

0.66x

For every $1 of reported earnings, Renasant generates $0.66 in operating cash flow ($129.4M OCF vs $195.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

This page shows Renasant (RNST) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$887.8M

YoY+11.3%

5Y CAGR+10.3%

10Y CAGR+14.6%

Renasant generated $887.8M in revenue in fiscal year 2024. This represents an increase of 11.3% from the prior year.

EBITDA

N/A

Free Cash Flow

$115.8M

YoY-8.8%

5Y CAGR-2.1%

10Y CAGR+1.2%

Renasant generated $115.8M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 8.8% from the prior year.

Net Income

$195.5M

YoY+35.1%

5Y CAGR+3.1%

10Y CAGR+12.6%

Renasant reported $195.5M in net income in fiscal year 2024. This represents an increase of 35.1% from the prior year.

EPS (Diluted)

$3.27

YoY+27.7%

5Y CAGR+2.6%

10Y CAGR+5.7%

Renasant earned $3.27 per diluted share (EPS) in fiscal year 2024. This represents an increase of 27.7% from the prior year.

Cash & Debt

$1.1B

YoY+36.3%

5Y CAGR+21.4%

10Y CAGR+21.1%

Renasant held $1.1B in cash against $430.6M in long-term debt as of fiscal year 2024.

Dividends Per Share

$0.88

YoY+0.0%

5Y CAGR+0.2%

10Y CAGR+2.6%

Renasant paid $0.88 per share in dividends in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Shares Outstanding

64M

YoY+13.2%

5Y CAGR+2.3%

10Y CAGR+7.3%

Renasant had 64M shares outstanding in fiscal year 2024. This represents an increase of 13.2% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

22.0%

YoY+3.9pp

5Y CAGR-8.9pp

10Y CAGR-4.3pp

Renasant's net profit margin was 22.0% in fiscal year 2024, showing the share of revenue converted to profit. This is up 3.9 percentage points from the prior year.

Return on Equity

7.3%

YoY+1.0pp

5Y CAGR-0.6pp

10Y CAGR-1.1pp

Renasant's ROE was 7.3% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 1.0 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$13.6M

YoY-36.9%

5Y CAGR-17.2%

10Y CAGR-4.7%

Renasant invested $13.6M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 36.9% from the prior year.

RNST Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$887.8M+11.3%	$797.3M+47.2%	$541.8M+15.6%	$468.7M-5.9%	$498.1M-8.2%	$542.6M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$375.6M+35.1%	$278.0M+359.4%	$60.5M+35.4%	$44.7M-37.4%	$71.3M-27.9%	$98.9M
Income Tax	$49.5M+52.3%	$32.5M-28.1%	$45.2M-3.6%	$46.9M+136.6%	$19.8M-58.7%	$48.1M
Net Income	$195.5M+35.1%	$144.7M-12.9%	$166.1M-5.6%	$175.9M+110.3%	$83.7M-50.1%	$167.6M
EPS (Diluted)	$3.27+27.7%	$2.56-13.2%	$2.95-5.4%	$3.12+110.8%	$1.48-48.6%	$2.88

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$351.1M+2.1%	$343.9M+56.1%	$220.3M-2.2%	$225.3M+2.3%	$220.2M+3.3%	$213.2M+1.3%	$210.4M+2.3%	$205.7M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$127.6M+2.0%	$125.0M+45.2%	$86.1M-6.8%	$92.5M-2.9%	$95.2M+5.9%	$89.9M+6.4%	$84.5M+7.9%	$78.3M
Income Tax	$15.5M+838.6%	$1.6M-84.2%	$10.4M+108.7%	$5.0M-48.2%	$9.7M-2.5%	$9.9M+161.7%	$3.8M-64.8%	$10.8M
Net Income	$59.8M+5773.1%	$1.0M-97.5%	$41.5M-7.2%	$44.7M+15.2%	$38.8M-1.4%	$39.4M+40.1%	$28.1M-32.8%	$41.8M
EPS (Diluted)	$0.63+6200.0%	$0.01-98.5%	$0.65-7.1%	$0.70+1.4%	$0.69-1.4%	$0.70+42.9%	$0.49-33.8%	$0.74

RNST Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$18.0B+3.9%	$17.4B+2.2%	$17.0B+1.1%	$16.8B+12.6%	$14.9B+11.4%	$13.4B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.1B+36.3%	$801.4M+39.1%	$576.0M-69.3%	$1.9B+196.6%	$633.2M+52.6%	$414.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$988.9M-0.3%	$991.7M0.0%	$991.7M+5.5%	$939.7M0.0%	$939.7M0.0%	$939.7M
Total Liabilities	$15.4B+1.9%	$15.1B+1.4%	$14.9B+1.7%	$14.6B+14.1%	$12.8B+13.5%	$11.3B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$430.6M+0.3%	$429.4M+0.3%	$428.1M-9.1%	$471.2M-0.8%	$475.0M+26.2%	$376.5M
Total Equity	$2.7B+16.6%	$2.3B+7.6%	$2.1B-3.3%	$2.2B+3.6%	$2.1B+0.3%	$2.1B
Retained Earnings	$1.1B+14.9%	$952.1M+11.0%	$857.7M+15.7%	$741.6M+20.4%	$615.8M-0.3%	$617.4M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$26.7B+0.4%	$26.6B+45.7%	$18.3B+1.3%	$18.0B+3.0%	$17.5B+0.9%	$17.3B-0.1%	$17.4B+1.0%	$17.2B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.1B-21.4%	$1.4B+26.3%	$1.1B-0.1%	$1.1B+28.2%	$851.9M+0.9%	$844.4M+5.4%	$801.4M+8.1%	$741.2M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.4B-0.6%	$1.4B+43.6%	$988.9M0.0%	$988.9M-0.3%	$991.7M0.0%	$991.7M0.0%	$991.7M0.0%	$991.7M
Total Liabilities	$22.9B+0.2%	$22.8B+47.0%	$15.5B+1.2%	$15.4B+1.3%	$15.2B+0.9%	$15.0B-0.3%	$15.1B+0.8%	$14.9B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$558.9M+0.3%	$557.0M+28.5%	$433.3M+0.6%	$430.6M+0.5%	$428.7M+0.1%	$428.0M-0.3%	$429.4M+0.5%	$427.4M
Total Equity	$3.8B+1.2%	$3.8B+38.6%	$2.7B+1.8%	$2.7B+13.7%	$2.4B+1.4%	$2.3B+1.1%	$2.3B+2.9%	$2.2B
Retained Earnings	$1.1B+3.5%	$1.1B-1.8%	$1.1B+2.5%	$1.1B+8.8%	$1.0B+2.7%	$978.9M+2.8%	$952.1M+1.7%	$936.6M

RNST Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$129.4M-12.9%	$148.6M-74.1%	$574.0M+302.4%	$142.7M+73.5%	$82.2M-49.7%	$163.6M
Capital Expenditures	$13.6M-36.9%	$21.6M+45.8%	$14.8M-27.7%	$20.5M-27.4%	$28.3M-19.2%	$35.0M
Free Cash Flow	$115.8M-8.8%	$126.9M-77.3%	$559.2M+357.8%	$122.1M+126.3%	$54.0M-58.0%	$128.7M
Investing Cash Flow	-$298.0M-438.0%	-$55.4M+97.3%	-$2.0B-209.6%	-$660.0M+47.8%	-$1.3B-150.2%	-$505.9M
Financing Cash Flow	$459.3M+247.4%	$132.2M-21.1%	$167.6M-90.5%	$1.8B+25.7%	$1.4B+645.1%	$188.1M
Dividends Paid	$53.7M+6.9%	$50.3M+0.6%	$50.0M-0.1%	$50.0M-0.2%	$50.1M-1.5%	$50.9M
Share Buybacks	N/A	$0	$0-100.0%	$21.3M-13.2%	$24.6M-61.0%	$62.9M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$135.5M+275.3%	-$77.3M-172.8%	$106.2M-7.8%	$115.1M+334.5%	-$49.1M-175.4%	$65.1M-35.2%	$100.4M+26.1%	$79.7M
Capital Expenditures	$15.3M+50.7%	$10.2M+111.3%	$4.8M+48.8%	$3.2M-6.9%	$3.5M+5.5%	$3.3M-37.1%	$5.2M+29.7%	$4.0M
Free Cash Flow	$120.1M+237.3%	-$87.5M-186.3%	$101.3M-9.4%	$111.9M+312.9%	-$52.6M-185.1%	$61.8M-35.1%	$95.2M+25.9%	$75.6M
Investing Cash Flow	-$448.8M-1601.8%	$29.9M+110.2%	-$292.1M+15.7%	-$346.6M-371.9%	-$73.4M-345.1%	$30.0M+120.7%	-$144.6M+21.8%	-$184.9M
Financing Cash Flow	$18.5M-94.5%	$334.7M+80.7%	$185.2M+286.4%	$47.9M-63.1%	$130.0M+350.2%	-$52.0M-149.8%	$104.3M+203.9%	-$100.5M
Dividends Paid	$21.2M0.0%	$21.2M+48.2%	$14.3M+0.4%	$14.2M+12.5%	$12.6M-0.1%	$12.7M+0.6%	$12.6M0.0%	$12.6M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

RNST Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	22.0%+3.9pp	18.1%-12.5pp	30.6%-6.9pp	37.5%+20.7pp	16.8%-14.1pp	30.9%
Return on Equity	7.3%+1.0pp	6.3%-1.5pp	7.8%-0.2pp	8.0%+4.0pp	3.9%-4.0pp	7.9%
Return on Assets	1.1%+0.3pp	0.8%-0.1pp	1.0%-0.1pp	1.1%+0.5pp	0.6%-0.7pp	1.3%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.16-0.0	0.19-0.0	0.20-0.0	0.210.0	0.22+0.0	0.18
FCF Margin	13.0%-2.9pp	15.9%-87.3pp	103.2%+77.2pp	26.1%+15.2pp	10.8%-12.9pp	23.7%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	17.0%+16.7pp	0.3%-18.5pp	18.8%-1.0pp	19.9%+2.2pp	17.6%-0.9pp	18.5%+5.1pp	13.4%-7.0pp	20.3%
Return on Equity	1.6%+1.5pp	0.0%-1.5pp	1.5%-0.1pp	1.7%+0.0pp	1.7%-0.1pp	1.7%+0.5pp	1.2%-0.7pp	1.9%
Return on Assets	0.2%+0.2pp	0.0%-0.2pp	0.2%-0.0pp	0.3%+0.0pp	0.2%0.0pp	0.2%+0.1pp	0.2%-0.1pp	0.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.150.0	0.15-0.0	0.160.0	0.16-0.0	0.180.0	0.180.0	0.190.0	0.19
FCF Margin	34.2%+59.7pp	-25.4%-71.4pp	46.0%-3.7pp	49.6%+73.5pp	-23.9%-52.8pp	29.0%-16.3pp	45.2%+8.5pp	36.8%

Similar Companies

Fulton Financial FULT

$4.0B

Independent Bk Corp Mass INDB

$4.1B

Eastern Bankshares, Inc. EBC

$4.7B

United Cmnty Bks Blairsvle Ga UCB

$4.2B

First Bancorp P R FBP

$3.5B

Frequently Asked Questions

What is Renasant's annual revenue?

Renasant (RNST) reported $887.8M in total revenue for fiscal year 2024. This represents a 11.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Renasant's revenue growing?

Renasant (RNST) revenue grew by 11.3% year-over-year, from $797.3M to $887.8M in fiscal year 2024.

Is Renasant profitable?

Yes, Renasant (RNST) reported a net income of $195.5M in fiscal year 2024, with a net profit margin of 22.0%.

What is Renasant's earnings per share (EPS)?

Renasant (RNST) reported diluted earnings per share of $3.27 for fiscal year 2024. This represents a 27.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

How much debt does Renasant have?

As of fiscal year 2024, Renasant (RNST) had $1.1B in cash and equivalents against $430.6M in long-term debt.

What is Renasant's net profit margin?

Renasant (RNST) had a net profit margin of 22.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does Renasant pay dividends?

Yes, Renasant (RNST) paid $0.88 per share in dividends during fiscal year 2024.

What is Renasant's return on equity (ROE)?

Renasant (RNST) has a return on equity of 7.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Renasant's free cash flow?

Renasant (RNST) generated $115.8M in free cash flow during fiscal year 2024. This represents a -8.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Renasant's operating cash flow?

Renasant (RNST) generated $129.4M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Renasant's total assets?

Renasant (RNST) had $18.0B in total assets as of fiscal year 2024, including both current and long-term assets.

What are Renasant's capital expenditures?

Renasant (RNST) invested $13.6M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does Renasant have outstanding?

Renasant (RNST) had 64M shares outstanding as of fiscal year 2024.

What is Renasant's debt-to-equity ratio?

Renasant (RNST) had a debt-to-equity ratio of 0.16 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Renasant's return on assets (ROA)?

Renasant (RNST) had a return on assets of 1.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Renasant's Piotroski F-Score?

Renasant (RNST) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Renasant's earnings high quality?

Renasant (RNST) has an earnings quality ratio of 0.66x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Renasant?

Renasant (RNST) scores 64 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.